Abstract:Background: Interleukin (IL)-12 and 23 are heterodimeric cytokines composed of a common p40 subunit and p35 and p19 subunits, respectively.IL-23 is strongly implicated in the pathogenesis of inflammatory bowel disease.Aim: The aim of this study is to characterize the molecular regulation of Il23a gene expression and promoter activation in murine macrophages and experimental colitis.Results: Interferon-γ (IFN-γ) inhibits LPS-induced Il23a mRNA and IL-23 protein expression in murine bone marrow-derived macrophages (BMMs).A conserved nucleotide sequence across multiple species was identified in the promoter of the Il23a gene that contains an interferon stimulated response element (ISRE).In LPS and IFN-γ activated BMMs, chromatin immunoprecipitation and electrophoretic mobility shift assays demonstrate that interferon regulatory factors (IRFs) interact with this ISRE.Using a 1.8 kb murine Il23a luciferase reporter plasmid, LPS induces and IFN-γ inhibits LPSinduced p19 promoter activity in BMMs.Mutations in the ISRE abrogate IFN-γ inhibition of LPS-induced promoter activity.To understand the contribution of specific IRFs, IRF-1 was inhibited in BMMs by siRNA and experiments were performed in IRF-1 deficient (-/-) macrophages.IRF-1 knockdown and IRF-1-/-BMMs demonstrate increased LPS-induced IL-23 expression.Primary response genes have promoters that either exist in an open chromatin structure or undergo rapid nucleosomal remodeling.In contrast, secondary response genes with delayed induction kinetics require new protein synthesis prior to transcription initiation.Il23a expression in LPS-activated BMMs demonstrates rapid induction kinetics and unlike Il12b (established secondary response gene) is not dependent on new protein synthesis.Interestingly, LPS plus IFN-γ activated BMMs demonstrate loss of the IFN-γ inhibitory effect, suggesting IFN-γ mediated regulation of Il23a requires new protein synthesis.Il23a regulation was then studied in murine colitis models.Following intrarectal administration of TNBS, IRF-1-/-mice exhibit increased inflammation and increased colonic IL-23 expression compared to wild type (WT) mice.Additionally, we demonstrate mucosal regulation of IL-23 by the enteric microbiota using germ-free and conventionalized WT and colitis-prone IL-10-/-mice.Enteric bacteria induce significantly higher intestinal IL-23 expression in IL-10-/-mice compared with WT mice.Conclusions: IFN-γ and IRF-1 negatively regulate Il23a in murine macrophages and experimental colitis.Regulation of intestinal Il23a by the enteric microflora is a significant event in the initiation of chronic intestinal inflammation.

Protective Effect of a Novel Antibody Against TLR2 on Zymosan-Induced Acute Peritonitis in NF-κB Transgenic Mice.

Protective Effect of an Antibody Against Specific Extracellular Domain of TLR2 on Agonists-Driven Inflammatory and Allergic Response.

Short-term Use of MyD88 Inhibitor TJ-M2010-5 Prevents D-Galactosamine/lipopolysaccharide-induced Acute Liver Injury in Mice.

IFN-τ Alleviates Lipopolysaccharide-Induced Inflammation by Suppressing NF-κB and MAPKs Pathway Activation in Mice

Tectorigenin Protects Against Experimental Fulminant Hepatic Failure by Regulating the TLR4/mitogen‐activated Protein Kinase and TLR4/nuclear Factor‐κb Pathways and Autophagy

Lactobacillus fermentum ZYL0401 Attenuates Lipopolysaccharide-Induced Hepatic TNF-α Expression and Liver Injury via an IL-10- and PGE2-EP4-Dependent Mechanism.

Effects of Zinc Finger Protein A20 on Lipopolysaccharide (Lps)-Induced Pulmonary Inflammation/Anti-Inflammatory Mediators in an Acute Lung Injury/Acute Respiratory Distress Syndrome Rat Model.

Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.

Blockade of Complement Activation Product C5a Activity Using Specific Antibody Attenuates Intestinal Damage in Trinitrobenzene Sulfonic Acid Induced Model of Colitis

Dual TNF-α/IL-12p40 Interference as a Strategy to Protect Against Colitis Based on miR-16 Precursors With Macrophage Targeting Vectors.

Dual Tnf-Alpha/Il-12p40 Interference As A Strategy To Protect Against Colitis Based On Mir-16 Precursors With Macrophage Targeting Vectors

Activation of Both TLR and NOD Signaling Confers Host Innate Immunity-Mediated Protection Against Microbial Infection

A Novel Acute Lethal Liver Injury Mouse Model with Visualization of NF-κB Activity for Treatment of Severe Acute Liver Injury.

Anti-Inflammatory Effects of IL-27 in Zymosan-Induced Peritonitis: Inhibition of Neutrophil Recruitment Partially Explained by Impaired Mobilization from Bone Marrow and Reduced Chemokine Levels

ABCC transporter inhibition reduces zymosan-induced peritonitis

Monoclonal Antibody Against Mature Interleukin-18 Ameliorates Colitis in Mice and Improves Epithelial Barrier Function

Recombinant Tumor Necrosis Factor Alpha (TNF alpha) Peptide-Based Vaccine Ameliorates Acute and Chronic Murine Colitis

OP26 Programmable probiotic local delivery of anti-TNF-α nanobody to alleviate DSS-induced colitis

Repeated Stimulation of Toll-Like Receptor 2 and Dectin-1 Induces Chronic Pancreatitis in Mice Through the Participation of Acquired Immunity

Mast cell-mediated inhibition of abdominal neutrophil inflammation by a PEGylated TLR7 ligand

Endotoxin Tolerance Inhibits Lipopolysaccharide‐Initiated Acute Pulmonary Inflammation and Lung Injury in Rats by the Mechanism of Nuclear Factor‐κB